Adjusted EBITDA: Adjusted EBITDA for the third quarter of 2025 was $ (2.7) million, compared with $ (0.6) million for the third quarter of 2024. Year-to-date Adjusted EBITDA was $ (9.5) million, ...

Myomo ( ($MYO) ) has shared an announcement. On November 4, 2025, Myomo, Inc. entered into a Loan and Security Agreement with Avenue Capital ...

Myomo Inc ( (MYO)) has released its Q3 earnings. Here is a breakdown of the information Myomo Inc presented to its investors. Myomo, Inc. is a wearable medical robotics company specializing in devices ...

Good afternoon, and welcome to the Myomo Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I ...

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb ...

Myomo Inc ((MYO)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment ...

Myomo ranks at the top for Revenue Growth and Gross Profit among its peers. However, it ranks at the bottom for Return on ...

Alliance Global Partners raised the firm’s price target on Myomo (MYO) to $6.75 from $6 and keeps a Buy rating on the shares after the company reported Q4 results that were ahead of the firm’s ...